Opentrons
PrivateLast Round
Series D
Nov 20, 2025
Est. Valuation
$1.8B
Total Funding Raised
$258.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Opentrons operates in Healthcare & Life Sciences and is based in Long Island City, New York. Its latest recorded funding round was a Series D round in November 2025.
Opentrons is a biotechnology company that develops and manufactures affordable, open-source liquid handling robots and lab automation solutions to streamline scientific research and experimentation.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Workflow Automation, Industrial Robotics, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Opentrons Comparables
Compare Opentrons with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hamilton Company | 80% | |
| Eppendorf SE | 80% | |
| SPT Labtech | 79% |
For institutional investors. Book with your work email.
Opentrons Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 20, 2025 | ||||
| Series C | Sep 23, 2021 | ||||
| Series B | Aug 25, 2020 | ||||
| Series A | Mar 27, 2018 | ||||
| Seed | Mar 22, 2017 | ||||
Accelerator | Mar 23, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Opentrons Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series C |
| Khosla Ventures | Series C, Series A |
| SoftBank Group | Series C |
| Tapas Capital | Series C |
| Y Combinator | Accelerator, Series A, Series C |
| Sands Capital | Series C |
| Lerer Hippeau | Series A, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Launched OpentronsAI, a platform for laboratory automation using LLMs.
- Jul 29, 2026
Job posting discloses that thousands of institutions use its lab automation robots.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- adopts_technologyNov 2, 2026
Opentrons begins using Nvidia Isaac and Cosmos to generate physical-AI training data earlier in 2026.
- is_developingNov 2, 2026
New funding enables Opentrons to develop Flex hardware, intelligent experiment-analysis tools, and protocol-sharing software services to reduce human intervention in automated laboratory work.
- receives_financingOct 29, 2026
Opentrons secures $40M in Series E financing led by Avego, with additional investment from BroadOak Capital Partners, to expand laboratory robotics, software, and data infrastructure for automated scientific research in New York.
For institutional investors. Book with your work email.
Opentrons Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Opentrons's valuation, stock price, and market status.
Is Opentrons a public or private company?
Opentrons is a private company.
What is the current stock price of Opentrons?
Opentrons is a private company, so its shares have no public market price. Caplight tracks Opentrons's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Opentrons worth (valuation)?
Opentrons's valuation is estimated at $1.8B based on funding round data.
Can I buy Opentrons stock?
Opentrons shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Opentrons's last funding round?
Opentrons's most recent funding round was Series D on November 20, 2025.
Who are the main investors in Opentrons?
Key investors in Opentrons include SoftBank Investment Advisers, Khosla Ventures, SoftBank Group.
Will Opentrons IPO soon?
No public IPO plans have been announced for Opentrons.
How can I track Opentrons secondary market activity?
Caplight tracks bids, offers, and trades in Opentrons's shares on secondary markets.